| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $38.4M | +39.2% |
| SG&A Expense | $12.5M | +97.3% |
| Operating Income | -$50.9M | -416.6% |
| Pre-tax Income | -$42.3M | -282.4% |
| Income Tax | $0 | -100.0% |
| Net Income | -$42.3M | -286.0% |
| EPS (Basic) | -$2.18 | -260.3% |
| EPS (Diluted) | -$2.18 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.9M | +41.3% |
| Short-term Investments | $182.8M | +66.7% |
| Current Assets | $206.4M | +61.6% |
| Total Assets | $212.8M | +63.2% |
| Current Liabilities | $10.0M | +81.9% |
| Total Liabilities | $14.8M | +159.2% |
| Stockholders' Equity | $198.1M | +391.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.8M | -269.8% |
| Capital Expenditures | $514K | +24.2% |
| Investing Cash Flow | -$69.7M | -6.4% |
| Financing Cash Flow | $109.0M | +94.0% |
| Free Cash Flow | -$33.4M | -276.2% |
| -2825.0% |